Oncostatin M/OSM Antibody (17001.31)
Novus Biologicals, part of Bio-Techne | Catalog # NB120-10842
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse (Negative)
Cited:
Human
Applications
Validated:
Block/Neutralize, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Cited:
Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2A Clone # 17001.31
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant full length protein (Human) expressed in E. coli.
Localization
Secreted
Specificity
Does not cross-react with recombinant human IL-6, IL-11, CNTF, LIF and recombinant mouse OSM.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Endotoxin Level
Endotoxin level is < 0.1 EU/ug antibody as determined by the LAL (Limulus amebocyte lysate) method.
Applications for Oncostatin M/OSM Antibody (17001.31)
Application
Recommended Usage
ELISA
1:100-1:2000
Western Blot
1 ug/ml
Application Notes
The antibody neutralizes the biological activity of recombinant human OSM.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS and 5% Trehalose
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Oncostatin M/OSM
Alternate Names
MGC20461, oncostatin M, oncostatin-M
Gene Symbol
OSM
Additional Oncostatin M/OSM Products
Product Documents for Oncostatin M/OSM Antibody (17001.31)
Product Specific Notices for Oncostatin M/OSM Antibody (17001.31)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...